ISSN 1674-3865  CN 21-1569/R
主管:国家卫生和计划生育委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

Chinese Pediatrics of Integrated Traditional and Western Medicine ›› 2025, Vol. 17 ›› Issue (4): 346-350.doi: 10.20274/j.cnki.issn.2025.04.013

Previous Articles     Next Articles

Treatment for pediatric Henoch-Schönlein purpura based on the theory of "Xuanfu-Qixue-Luomai"

Yanli CUI1, Li XU2()   

  1. 1.Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
    2.The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110034, China
  • Received:2025-03-10 Revised:2025-05-14 Published:2025-08-25 Online:2025-08-25
  • Contact: Li XU E-mail:xuli18940158762@163.com
  • Supported by:
    National Natural Science Foundation of China(81603511)

Abstract:

Henoch-Sch?nlein purpura(HSP) is a common bleeding disease in children, and the incidence of HSP has been on the rise in recent years. Xuanfu, Qixue, and Luomai are closely related, and the pathological changes of Xuanfu-Qixue-Luomai axis are the microscopic manifestation of HSP. Xuanfu depression is the beginning of the onset of the disease, the disharmony of Qixue runs through the course of the disease, and the damage to the Luomai is the end of the disease. In the acute stage, the aim is mainly to dispel pathogens, attention is paid to regulating the Xuanfu-Qixue-Luomai axis, and treatment is to open Xuanfu, harmonize Qixue, and unclog Luomai. During the deferment period, the aim is to strengthen the body's resistance, and attention is paid to the regulation of viscera. The method of promoting blood circulation and eliminating blood stasis runs throughout the treatment. Based on the "Xuanfu-Qixue-Luomai" theory, this article explores the pathogenesis and the treatment strategies of childhood Henoch-Sch?nlein purpura, providing new ideas for the traditional Chinese medicine treatment of this disease.

Key words: Henoch-Sch?nlein purpura, Xuanfu, Qixue, Luomai, Child

CLC Number: